Marker Therapeutics Ownership 2024 | Who Owns Marker Therapeutics Now?

Overview RevenueFinancials Chart

Institutional Ownership

0.79%

Insider Ownership

12.20%

Retail Ownership

87.01%

Institutional Holders

1.00

Marker Therapeutics Institutional Shareholders

Institutional Shareholders by % of Total Shares

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
AR ASSET MANAGEMENT INC	0.79%	0.09%	70,700	-	-	384,000	Jun 30, 2024

Marker Therapeutics's largest institutional shareholder is AR ASSET MANAGEMENT INC, holding 0.79% of the company's total share outstanding, currently valued at $384.00K. The top 10 institutional shareholders own together 0.79% of the company.

Institutional Shareholders by % of Total Assets

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
AR ASSET MANAGEMENT INC	0.79%	0.09%	70,700	-	-	384,000	Jun 30, 2024

The largest Marker Therapeutics shareholder by % of total assets is AR ASSET MANAGEMENT INC. The company owns 70.70K shares of Marker Therapeutics (MRKR), representing 0.09% of its total assets.

Institutional Buyers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
AR ASSET MANAGEMENT INC	0.79%	0.09%	70,700	-	-	384,000	Jun 30, 2024

As of Jun 30 2024, Marker Therapeutics's largest institutional buyer is AR ASSET MANAGEMENT INC. The company purchased 0.00 stocks of MRKR, valued at $384.00K.

Institutional Sellers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
AR ASSET MANAGEMENT INC	0.79%	0.09%	70,700	-	-	384,000	Jun 30, 2024

As of Jun 30 2024, Marker Therapeutics's biggest institutional seller is AR ASSET MANAGEMENT INC. The company sold 0.00 shares of MRKR, valued at $384.00K.

Institutional New positions

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date

Institutional Sold Out

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date

Marker Therapeutics Mutual Fund Holders

Name	% Total Assets	Total Shares	Change Amount	Change %	Date
VANGUARD VALLEY FORGE FUNDS	0.11%	54,947	-	-	Mar 31, 2024
BRIDGEWAY FUNDS INC	0.10%	242,416	-	-	Mar 28, 2024
FIDELITY COMMONWEALTH TRUST	0.02%	65,462	-	-	Feb 29, 2024
VICTORY PORTFOLIOS	0.01%	445,930	-	-	Mar 31, 2024
DEUTSCHE DWS INVESTMENTS VIT FUNDS	0.01%	5,003	-	-	Mar 31, 2024
ALPS ETF Trust	0.01%	98,455	-	-	Feb 29, 2024
QUANTITATIVE MASTER SERIES LLC	0.01%	45,421	-	-	Mar 31, 2024
SSGA FUNDS	0.01%	2,645	-	-	Feb 29, 2024
TIAA SEPARATE ACCOUNT VA 1	0.01%	1,309	-	-	Mar 31, 2024
VANGUARD INDEX FUNDS	0.00%	1,630,877	-	-	Mar 31, 2024
FIDELITY CONCORD STREET TRUST	0.00%	546,237	-	-	Feb 29, 2024
VANGUARD INSTITUTIONAL INDEX FUNDS	0.00%	56,903	-	-	Mar 31, 2024
Investment Managers Series Trust II	0.00%	21,534	-	-	Jan 31, 2024
VANGUARD VALLEY FORGE FUNDS	0.00%	820	-	-	Mar 31, 2024
Calvert Variable Products, Inc.	0.00%	2,391	-	-	Mar 31, 2024
SCHWAB CAPITAL TRUST	0.00%	26,562	-	-	Feb 29, 2024
HC CAPITAL TRUST	0.00%	19,534	-	-	Mar 31, 2024
Voya VARIABLE PORTFOLIOS INC	0.00%	16,012	-	-	Mar 31, 2024
SunAmerica Specialty Series	0.00%	243	-	-	Apr 30, 2021
VANGUARD WORLD FUND	0.00%	70,989	-	-	Feb 29, 2024
RUSSELL INVESTMENT CO	0.00%	62,205	-	-	Jan 31, 2024
NORTHERN FUNDS	0.00%	18,088	-	-	Mar 28, 2024
DFA INVESTMENT DIMENSIONS GROUP INC	0.00%	82,125	-	-	Jan 31, 2024
STATE STREET INSTITUTIONAL INVESTMENT TRUST	0.00%	4,870	-	-	Mar 31, 2024
FIDELITY SALEM STREET TRUST	0.00%	297,105	-	-	Mar 31, 2024
ProFunds	0.00%	661	-	-	Mar 31, 2024
TIAA-CREF FUNDS	0.00%	166,747	-	-	Mar 31, 2024
VALIC Co I	0.00%	14,457	-	-	Feb 29, 2024
ALLSPRING MASTER TRUST	0.00%	3,198	-	-	Feb 29, 2024
VANGUARD SCOTTSDALE FUNDS	0.00%	94,765	-	-	Feb 29, 2024
PENN SERIES FUNDS INC	0.00%	1,100	-	-	Mar 28, 2024
NATIONWIDE MUTUAL FUNDS	0.00%	4,372	-	-	Jan 31, 2024
NATIONWIDE VARIABLE INSURANCE TRUST	0.00%	4,374	-	-	Mar 31, 2024
DFA INVESTMENT DIMENSIONS GROUP INC	0.00%	31,800	15,900	100.00%	Jan 31, 2024
USAA MUTUAL FUNDS TRUST	0.00%	6,452	-	-	Jan 31, 2024
COLLEGE RETIREMENT EQUITIES FUND	0.00%	24,518	-	-	Mar 31, 2024
VANGUARD WELLINGTON FUND	0.00%	8,417	-	-	Feb 29, 2024
PACE SELECT ADVISORS TRUST	0.00%	6,111	-	-	Jan 31, 2024
T. Rowe Price Index Trust, Inc.	0.00%	371	-	-	Feb 29, 2024
VANGUARD INSTITUTIONAL INDEX FUNDS	0.00%	462	-	-	Mar 31, 2024
LINCOLN VARIABLE INSURANCE PRODUCTS TRUST	0.00%	33,200	-	-	Mar 31, 2024
Dimensional ETF Trust	0.00%	5,437	-	-	Jan 31, 2024
MORGAN STANLEY PATHWAY FUNDS	0.00%	1,128	-	-	Feb 29, 2024
Dimensional ETF Trust	0.00%	4,378	-	-	Jan 31, 2024
SUNAMERICA SERIES TRUST	0.00%	3,294	-	-	Mar 31, 2024
EQ ADVISORS TRUST	0.00%	10,174	-	-	Mar 31, 2024
WILSHIRE MUTUAL FUNDS INC	0.00%	2,160	-	-	Dec 31, 2023
iSHARES TRUST	0.00%	108,538	-	-	Mar 31, 2024
Principal Exchange-Traded Funds	0.00%	64	-	-	Mar 31, 2024
PACIFIC SELECT FUND	0.00%	18,565	-	-	Mar 31, 2024
MASSMUTUAL SELECT FUNDS	0.00%	4,330	-	-	Dec 31, 2023
Bridge Builder Trust	0.00%	14,082	-	-	Mar 31, 2024
USAA MUTUAL FUNDS TRUST	0.00%	697	-	-	Jan 31, 2024
JOHN HANCOCK VARIABLE INSURANCE TRUST	0.00%	2,986	-	-	Mar 31, 2024
BlackRock Variable Series Funds, Inc.	0.00%	3,653	-	-	Mar 31, 2024
PRINCIPAL FUNDS, INC.	0.00%	3,821	-	-	Feb 29, 2024
SEI INSTITUTIONAL INVESTMENTS TRUST	0.00%	11,600	-	-	Feb 29, 2024
Advisors' Inner Circle Fund III	0.00%	18	-	-	Jan 31, 2024
BLACKROCK FUNDS	0.00%	1,128	-	-	Mar 28, 2024

Marker Therapeutics's largest mutual fund holder by % of total assets is "VANGUARD VALLEY FORGE FUNDS", owning 54.95K shares, compromising 0.11% of its total assets.

Marker Therapeutics Institutional Ownership Trends

Institutional Holdings Trend

Date	Holdings	Change %
30 Jun, 24	1	-
31 Mar, 24	1	-
31 Dec, 23	1	-
30 Sep, 23	1	-
30 Jun, 23	1	-50.00%
31 Mar, 23	2	-95.35%
31 Dec, 22	43	13.16%
30 Sep, 22	38	-11.63%
30 Jun, 22	43	-8.51%
31 Mar, 22	47	-22.95%
31 Dec, 21	61	-6.15%
30 Sep, 21	65	-13.33%
30 Jun, 21	75	-2.60%
31 Mar, 21	77	26.23%
31 Dec, 20	61	1.67%
30 Sep, 20	60	-9.09%
30 Jun, 20	66	1.54%
31 Mar, 20	65	-7.14%
31 Dec, 19	70	-11.39%
30 Sep, 19	79	6.76%
30 Jun, 19	74	34.55%
31 Mar, 19	55	25.00%
31 Dec, 18	44	4300.00%
30 Sep, 18	1	-

As of 30 Jun 24, 1 institutions are holding Marker Therapeutics's shares, representing an increase of 0.00% compared to the previous quarter.

Shares Outstanding Trend

Date	Shares Outstanding	Change %
30 Jun, 24	70,700	-
31 Mar, 24	70,700	-
31 Dec, 23	70,700	-
30 Sep, 23	70,700	73.71%
30 Jun, 23	40,700	-88.53%
31 Mar, 23	354,986	-98.18%
31 Dec, 22	19,537,213	-4.37%
30 Sep, 22	20,430,222	-8.20%
30 Jun, 22	22,254,399	-4.50%
31 Mar, 22	23,303,937	-11.81%
31 Dec, 21	26,423,202	0.14%
30 Sep, 21	26,386,060	-2.68%
30 Jun, 21	27,113,569	6.74%
31 Mar, 21	25,401,654	80.33%
31 Dec, 20	14,085,831	-0.31%
30 Sep, 20	14,130,285	-0.53%
30 Jun, 20	14,205,458	-4.63%
31 Mar, 20	14,895,685	-4.24%
31 Dec, 19	15,555,854	-9.76%
30 Sep, 19	17,237,413	-6.12%
30 Jun, 19	18,361,950	20.01%
31 Mar, 19	15,300,101	-1.77%
31 Dec, 18	15,576,264	437067.11%
30 Sep, 18	3,563	-

Marker Therapeutics (MRKR) has 70.70K shares outstanding as of 30 Jun 24, up 0.00% compared to the previous quarter.

Institutional Ownership Trend

Date	Ownership %	Change %
30 Jun, 24	0.79%	125.86%
31 Mar, 24	0.79%	123.79%
31 Dec, 23	0.80%	124.07%
30 Sep, 23	0.80%	368.91%
30 Jun, 23	0.47%	2.82%
31 Mar, 23	4.07%	0.24%
31 Dec, 22	41.53%	2.20%
30 Sep, 22	43.43%	1.94%
30 Jun, 22	47.31%	1.93%
31 Mar, 22	49.54%	2.26%
31 Dec, 21	46.79%	2.14%
30 Sep, 21	46.73%	2.03%
30 Jun, 21	48.01%	2.37%
31 Mar, 21	44.98%	4.98%
31 Dec, 20	30.05%	3.31%
30 Sep, 20	30.15%	3.24%
30 Jun, 20	30.50%	2.92%
31 Mar, 20	32.32%	2.78%
31 Dec, 19	34.12%	2.39%
30 Sep, 19	37.76%	2.32%
30 Jun, 19	40.35%	3.56%
31 Mar, 19	33.65%	2.87%
31 Dec, 18	34.26%	56047065.38%
30 Sep, 18	0.01%	-

As of 30 Jun 24, Marker Therapeutics is held by 0.79% institutional shareholders, representing a 125.86% growth compared to 31 Mar 24.

Institutional Increased Positions Trend

Date	Increased Positions	Change %
30 Jun, 24	-	-
31 Mar, 24	-	-
31 Dec, 23	-	-100.00%
30 Sep, 23	1	-
30 Jun, 23	-	-100.00%
31 Mar, 23	1	-95.00%
31 Dec, 22	20	150.00%
30 Sep, 22	8	-
30 Jun, 22	8	-46.67%
31 Mar, 22	15	-16.67%
31 Dec, 21	18	20.00%
30 Sep, 21	15	-51.61%
30 Jun, 21	31	-26.19%
31 Mar, 21	42	68.00%
31 Dec, 20	25	25.00%
30 Sep, 20	20	-33.33%
30 Jun, 20	30	30.43%
31 Mar, 20	23	-28.13%
31 Dec, 19	32	-23.81%
30 Sep, 19	42	-8.70%
30 Jun, 19	46	39.39%
31 Mar, 19	33	-23.26%
31 Dec, 18	43	4200.00%
30 Sep, 18	1	-

- institutional shareholders have increased their position in MRKR stock as of 30 Jun 24 compared to - in the previous quarter (a 0.00% increase).

Institutional Reduced Positions Trend

Date	Reduced Positions	Change %
30 Jun, 24	-	-
31 Mar, 24	-	-
31 Dec, 23	-	-
30 Sep, 23	-	-
30 Jun, 23	-	-100.00%
31 Mar, 23	1	-83.33%
31 Dec, 22	6	-33.33%
30 Sep, 22	9	-30.77%
30 Jun, 22	13	18.18%
31 Mar, 22	11	-59.26%
31 Dec, 21	27	3.85%
30 Sep, 21	26	8.33%
30 Jun, 21	24	50.00%
31 Mar, 21	16	-
31 Dec, 20	16	-11.11%
30 Sep, 20	18	38.46%
30 Jun, 20	13	-43.48%
31 Mar, 20	23	43.75%
31 Dec, 19	16	45.45%
30 Sep, 19	11	-
30 Jun, 19	11	83.33%
31 Mar, 19	6	-
31 Dec, 18	-	-
30 Sep, 18	-	-

- institutional shareholders have reduced their position in MRKR stock as of 30 Jun 24 compared to - in the previous quarter (a 0.00% increase).

All Institutional Ownership Trend Data

Date	Holdings	Change %	Shares Outstanding	Change %	Ownership %	Change %	Increased Positions	Change %	Reduced Positions	Change %
30 Jun, 24	1	-	70,700	-	0.79%	125.86%	-	-	-	-
31 Mar, 24	1	-	70,700	-	0.79%	123.79%	-	-	-	-
31 Dec, 23	1	-	70,700	-	0.80%	124.07%	-	-100.00%	-	-
30 Sep, 23	1	-	70,700	73.71%	0.80%	368.91%	1	-	-	-
30 Jun, 23	1	-50.00%	40,700	-88.53%	0.47%	2.82%	-	-100.00%	-	-100.00%
31 Mar, 23	2	-95.35%	354,986	-98.18%	4.07%	0.24%	1	-95.00%	1	-83.33%
31 Dec, 22	43	13.16%	19,537,213	-4.37%	41.53%	2.20%	20	150.00%	6	-33.33%
30 Sep, 22	38	-11.63%	20,430,222	-8.20%	43.43%	1.94%	8	-	9	-30.77%
30 Jun, 22	43	-8.51%	22,254,399	-4.50%	47.31%	1.93%	8	-46.67%	13	18.18%
31 Mar, 22	47	-22.95%	23,303,937	-11.81%	49.54%	2.26%	15	-16.67%	11	-59.26%
31 Dec, 21	61	-6.15%	26,423,202	0.14%	46.79%	2.14%	18	20.00%	27	3.85%
30 Sep, 21	65	-13.33%	26,386,060	-2.68%	46.73%	2.03%	15	-51.61%	26	8.33%
30 Jun, 21	75	-2.60%	27,113,569	6.74%	48.01%	2.37%	31	-26.19%	24	50.00%
31 Mar, 21	77	26.23%	25,401,654	80.33%	44.98%	4.98%	42	68.00%	16	-
31 Dec, 20	61	1.67%	14,085,831	-0.31%	30.05%	3.31%	25	25.00%	16	-11.11%
30 Sep, 20	60	-9.09%	14,130,285	-0.53%	30.15%	3.24%	20	-33.33%	18	38.46%
30 Jun, 20	66	1.54%	14,205,458	-4.63%	30.50%	2.92%	30	30.43%	13	-43.48%
31 Mar, 20	65	-7.14%	14,895,685	-4.24%	32.32%	2.78%	23	-28.13%	23	43.75%
31 Dec, 19	70	-11.39%	15,555,854	-9.76%	34.12%	2.39%	32	-23.81%	16	45.45%
30 Sep, 19	79	6.76%	17,237,413	-6.12%	37.76%	2.32%	42	-8.70%	11	-
30 Jun, 19	74	34.55%	18,361,950	20.01%	40.35%	3.56%	46	39.39%	11	83.33%
31 Mar, 19	55	25.00%	15,300,101	-1.77%	33.65%	2.87%	33	-23.26%	6	-
31 Dec, 18	44	4300.00%	15,576,264	437067.11%	34.26%	56047065.38%	43	4200.00%	-	-
30 Sep, 18	1	-	3,563	-	0.01%	-	1	-	-	-

Marker Therapeutics Insider Shareholders Trades

Open Market Insider Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source
Jun 08, 2023	Eansor Norman David	director	-	P-Purchase	Buy	14,285	$17.50	$249.99K	16,713

Open Market Insider Buys

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source
Jun 08, 2023	Eansor Norman David	director	-	P-Purchase	Buy	14,285	$17.50	$249.99K	16,713

Insider Sells

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source
Jun 08, 2023	Eansor Norman David	director	-	G-Gift	Sell	14,285	-	-	2,428

All Insider Owners Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Jul 05, 2023	Lurier Eliot M	officer	-		Buy	-	-	-	-
Jun 08, 2023	Eansor Norman David	director	-	P-Purchase	Buy	14,285	$17.50	$249.99K	16,713
Jun 08, 2023	Eansor Norman David	director	-	A-Award	Buy	8,000	$1.72	$13.76K	8,000
Jun 08, 2023	Eansor Norman David	director	-	G-Gift	Buy	7,142	-	-	7,142
Jun 08, 2023	Eansor Norman David	director	-	G-Gift	Sell	14,285	-	-	2,428
Jun 08, 2023	Knobil Katharine	director	-	A-Award	Buy	8,000	$1.72	$13.76K	8,000
Jun 08, 2023	Wilson John Robert	director	-	A-Award	Buy	8,000	$1.72	$13.76K	8,000
Jun 08, 2023	ELMS STEVE	director	-	A-Award	Buy	8,000	$1.72	$13.76K	8,000
May 11, 2023	Vera Juan	director, officer	President and CEO	A-Award	Buy	100,000	$1.42	$142.00K	100,000
Mar 01, 2023	Hoang Tsvetelina P	officer	VP, Research and Development	A-Award	Buy	33,159	$2.14	$70.96K	33,159
Mar 01, 2023	Koneru Mythili	officer	Chief Medical Officer	A-Award	Buy	51,918	$2.14	$111.10K	51,918
Mar 01, 2023	Loiacono Michael	officer	Chief Accounting Officer	A-Award	Buy	38,480	$2.14	$82.35K	38,480
Mar 01, 2023	Vera Juan	director, officer	Chief Scientific Officer & COO	A-Award	Buy	46,487	$2.14	$99.48K	46,487
Mar 01, 2023	Szymanska Anna	officer	Vice President, Quality	A-Award	Buy	29,947	$2.14	$64.09K	29,947
Mar 01, 2023	Agopyan Nadia	officer	SVP, Regulatory Affairs	A-Award	Buy	34,154	$2.14	$73.09K	34,154
May 26, 2022	Wilson John Robert	director		A-Award	Buy	80,000	-	-	80,000
May 26, 2022	Laskow-Pooley David	director		A-Award	Buy	80,000	-	-	80,000
May 26, 2022	Knobil Katharine	director		A-Award	Buy	80,000	-	-	80,000
May 26, 2022	Knobil Katharine	director	-	A-Award	Buy	80,000	$0.34	$27.02K	80,000
May 26, 2022	ELMS STEVE	director		A-Award	Buy	80,000	-	-	80,000

The last insider sell of Marker Therapeutics's stock was made by Eansor Norman David on Jun 08 2023, selling 14,285 shares at - per share (valued at -). The last insider buy of MRKR was made by Eansor Norman David on Jun 08 2023, buying 14,285 shares at $17.50 per share (worth $249.99K).

Marker Therapeutics Insider Ownership Trends

All Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q2 2023	1	-	-
Q1 2023	6	-	-
Q2 2022	5	-	-
Q1 2022	12	3	400.00%
Q4 2021	1	-	-
Q2 2021	6	-	-
Q1 2021	23	-	-
Q4 2020	-	-	-
Q2 2020	-	1	-
Q1 2020	19	4	475.00%
Q3 2019	3	-	-
Q2 2019	4	1	400.00%
Q4 2018	13	12	108.33%
Q3 2018	1	-	-
Q2 2018	1	-	-
Q1 2018	7	-	-
Q3 2017	7	2	350.00%
Q1 2017	2	-	-
Q4 2016	3	2	150.00%
Q3 2016	6	1	600.00%

1 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Marker Therapeutics's insiders, as of Q2 2023.

Open Market Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q2 2023	-	-	-
Q1 2023	-	-	-
Q2 2022	-	-	-
Q1 2022	-	-	-
Q4 2021	-	-	-
Q2 2021	1	-	-
Q1 2021	14	-	-
Q4 2020	-	-	-
Q2 2020	-	-	-
Q1 2020	-	-	-
Q3 2019	1	-	-
Q2 2019	-	-	-
Q4 2018	-	-	-
Q3 2018	-	-	-
Q2 2018	1	-	-
Q1 2018	-	-	-
Q3 2017	-	-	-
Q1 2017	-	-	-
Q4 2016	-	-	-
Q3 2016	-	-	-

As of Q2 2023, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Marker Therapeutics's stocks.

Marker Therapeutics Peer Ownership

Ticker	Company
PMVP	PMV Pharmaceuticals, Inc.
IKNA	Ikena Oncology, Inc.
XCUR	Exicure, Inc.
EWTX	Edgewise Therapeutics, Inc.
ALEC	Alector, Inc.
AVTE	Aerovate Therapeutics, Inc.
ACRV	Acrivon Therapeutics, Inc. Common Stock
KROS	Keros Therapeutics, Inc.
AGEN	Agenus Inc.
RNXT	RenovoRx, Inc.
TPST	Tempest Therapeutics, Inc.
ANEB	Anebulo Pharmaceuticals, Inc.
BNOX	Bionomics Limited
PTIX	Protagenic Therapeutics, Inc.
CBIO	Gyre Therapeutics, Inc.
AADI	Aadi Bioscience, Inc.
LUMO	Lumos Pharma, Inc.
GRTX	Galera Therapeutics, Inc.

MRKR Ownership FAQ

Who Owns Marker Therapeutics?

Marker Therapeutics is owned by institutional shareholders (0.79%), insiders (12.20%), and public (87.01%). The largest institutional shareholder of Marker Therapeutics is AR ASSET MANAGEMENT INC (0.79% of total shares) and the top mutual fund owner is VANGUARD VALLEY FORGE FUNDS (0.11% of total shares).

Who are the major institutional shareholders of Marker Therapeutics?

Marker Therapeutics's major institutional shareholders are AR ASSET MANAGEMENT INC. The top five shareholders own together 0.79% of the company's share outstanding.

How many Marker Therapeutics shareholders are there?

As of Jun 2024, there are 1 institutional shareholders of Marker Therapeutics.

What percentage of Marker Therapeutics is owned by AR ASSET MANAGEMENT INC?

AR ASSET MANAGEMENT INC owns 70.7K shares of Marker Therapeutics, representing 0.79% of the company's total shares outstanding, valued at $384K (as of Jun 2024).